Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort

Rodrigo Sánchez-Bayona, Alfonso López de, Yolanda Jeréz Gilarranz, Ana Sanchez de Torre, Manuel Alva, Isabel Echavarría, Fernando Moreno, Pablo Tolosa, B. Herrero Lopez, Alicia de Luna, Laura Lema, Salvador Gámez Casado, Ainhoa Madariaga, Sara López‐Tarruella, Luís Manso, Coralia Bueno, José Á. García-Sáenz, Eva Ciruelos, Miguel Martín